SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (12930)1/1/1998 5:13:00 PM
From: michael meyers  Respond to of 32384
 
re: "A loss of 51 cents for the year is less than $20 million, which strongly suggests that there will be no secondary."

Perhaps. However, remember that accounting numbers have nothing [well, very little] to do with cash flow. If LGND is capitalizing any expenses then they might need the secondary for cash reasons.

Michael


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News